Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Dronabinol use in France between 2004 and 2017.

< BACK TO ARCHIVE


2019 May


Rev Neurol (Paris)


http://www.ncbi.nlm.nih.gov/pubmed/30948262?dopt=Abstract


175


5

Dronabinol use in France between 2004 and 2017.

Authors

Dronabinol use in France between 2004 and 2017.
Lejczak S, Rousselot H, Di Patrizio P, Debouverie M
Rev Neurol (Paris). 2019 May; 175(5):298-304.
PMID: 30948262.

Abstract

To investigate prescription practices for dronabinol, a pure extract of delta-9-tetrahydrocannabinol, prescribed for refractory chronic pain in France since 2004.
Read This Paper